The Migraine World Summit is the largest patient event in the world for migraine and headache disorders. The Migraine World Summit will bring together 32 experts, including doctors and specialists, to share new treatments, research, and strategies to help you improve your migraine and chronic…
As part of its 2018 funding cycle, the National Headache Foundation has awarded a $100,000 grant to fund a nationwide study conducted by Dr. Erin Buchanan of Harrisburg University of Science and Technology and Clinvest Research. The goal of the project will be to improve…
The National Headache Foundation is proud to be participating in Headache on the Hill, an annual congressional advocacy event on February 11 and 12, 2019. Headache on the Hill participants visit the offices of approximately 130 members of Congress to raise issues on behalf of those…
The National Headache Foundation applauds the approval and release of Teva Pharmaceutical’s migraine preventive medication, Ajovy (fremenazumab), on Friday, September 14, 2018. This medication is the second in a new class of migraine preventers called CGRP monoclonal antibodies to be approved in 2018, with another…
The National Headache Foundation has begun to conduct surveys with thousands of our patient members on important topics: affordability of care; meaningful migraine relief; satisfaction with medications and treatment; etc. The results are accumulating and we are beginning to analyze some of the data. …
With spring comes warmer weather, rain showers, fresh flowers and the dreaded seasonal allergy symptoms. Frequent sneezing and itchy eyes are common this time of year, and some people may even experience intensified or continual migraine. It’s important to know, however, whether or not ongoing…
Pain is cited as the most common reason Americans access health care. It is a leading cause of disability and it is a major contributor to health care costs. It is important that your voice is heard if we are to improve the care of people…
The National Headache Foundation has been supporting clinical and basic science research in headache and its causes for over 25 years. These grants have served as springboards to obtaining over $7 million in federal funding of headache-related research. Newer resources have facilitated the application process…
Individuals with asthma who also experience episodic or occasional migraine may be more likely to develop chronic migraine, according to a National Headache Foundation-sponsored study, recently published online in the journal Headache. “If you have asthma along with episodic or occasional migraine, then your headaches…
The study found that approximately 12 percent of Americans have migraines, and approximately 40 percent could benefit from preventive therapies. (1) Of migraine sufferers in the study, only one in five currently use preventive therapy. (1) Nine out of 10 migraine sufferers report they can’t…
Subscribe to our Newsletter
Gain access to the most current migraine and headache information, prevention,
treatment, research, and news.
